<a href="https://laohu8.com/S/ATXS">Astria Therapeutics Inc</a>. Conducted Annual Stockholders Meeting
Astria Therapeutics Inc. held its Annual Meeting of Stockholders on June 11, 2025. The stockholders elected Jill C. Milne, Fred Callori, and Michael Kishbauch as Class I directors to the Board of Directors. The amendment to the Second Amended and Restated 2015 Stock Incentive Plan, increasing the number of shares that may be issued by 5,500,000, was approved. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Astria Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-058887), on June 12, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。